Mr Ornskov, Chief Executive of Shire pharmaceuticals is seeking to expand Vyvanse into new areas, well he would, wouldn’t he. This is a HUGE market.
Vyvanse is an amphetamine – like drug which can lead to an addiction in a population already struggling with control issues. It may have an effect on impulse control, but impulse control is not the main issue present for binge eaters.
Lisdexamfetamine has a high risk for abuse. It may be habit-forming if used for a long period of time. Abuse of Lisdexamfetamine may cause serious heart problems, blood vessel problems, or sudden death. We have been here before.
Will it cure binge eating? I think not. Is there anything we can do to prevent Shire from getting approval to market this drug to a gullible public. I fear not.